A phase 1 dose escalation study of the oncolytic adenovirus enadenotucirev, administered intravenously to patients with epithelial solid tumors (EVOLVE)
========================================================================================================================================================

* Jean-Pascal Machiels
* Ramon Salazar
* Sylvie Rottey
* Ignacio Duran
* Luc Dirix
* Karen Geboes
* Christine Wilkinson-Blanc
* Gillian Pover
* Simon Alvis
* Brian Champion
* Kerry Fisher
* Hilary McElwaine-Johnn
* John Beadle
* Emiliano Calvo